Summary:
Open label trial evaluating the safety and efficacy of a medication to treat pain due to Multiple Sclerosis.
Qualified Participants Must:
• Be 18 to 75 years of age
•
Have been diagnosed with Multiple Sclerosis
•
Have chronic, constant or persistent daily pain present for 2 months or more
•
Be on stable analgesic regimen for one month or more
Qualified Participants May Receive:
All study related care and medication. Compensation is also available.